Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes.It was founded in 2016 and is headquartered in San Francisco, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 5, 2021 | Seed | $5.90M | 4 | Khosla Ventures SV Latam Capital | — | Detail |
Aug 22, 2019 | Seed | — | 4 | — | — | Detail |
May 1, 2017 | Grant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Khosla Ventures | Yes | Seed |
SV Latam Capital | Yes | Seed |
Sand Hill Angels | — | Seed |
Y Combinator | — | Seed |
Formic Ventures | — | Seed |
MedTech Innovator | — | Grant |